Structure-based design of cyclin-dependent kinase inhibitors-Reference-Cited by-同舟云学术

Structure-based design of cyclin-dependent kinase inhibitors

Published:2002-02 Issue:2-3 Volume:93 Page:125-133
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Davies Thomas G.,Pratt David J.,Endicott Jane A.,Johnson Louise N.,Noble Martin E.M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles;Arris;J. Med. Chem.,2000

2. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs;Böhm;J. Comput-Aided Mol Des,1998

3. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases;Brown;Nat Cell Biol,1999

4. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma;Bruns;Cancer Res,2000

5. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists;Chen;Proc. Natl. Acad. Sci. USA,1999

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy;Future Medicinal Chemistry;2024-01-30

2. Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors;Frontiers in Chemistry;2022-11-25

3. The texture evolution related to the interactions between α and β phases in dual-phase region annealing of a near α titanium alloy pipe after Pilger cold rolling;Journal of Alloys and Compounds;2022-01

4. Advances in Pyrazole Based Scaffold as Cyclin-Dependent Kinase 2 Inhibitors for the Treatment of Cancer;Mini-Reviews in Medicinal Chemistry;2021-10-27

5. Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure;European Journal of Medicinal Chemistry;2021-04